Article
Is oxygen a key factor in the lipodystrophy phenotype?
Lipids in health and disease - 18 Oct 2006
Gentil Christel, Le Jan Sébastien, Philippe Josette, Leibowitch Jacques, Sonigo Pierre, Germain Stéphane, Piétri-Rouxel France
Abstract excerpt
BACKGROUND: The lipodystrophic syndrome (LD) is a disorder resulting from selective damage of adipose tissue by antiretroviral drugs included in therapy controlling human-immunodeficiency-virus-1. In the therapy cocktail the nucleoside reverse transcriptase inhibitors (NRTI) contribute to the dev...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
